A

Annexon Biosciences

Develops C1q inhibitor therapies

Vice President, Marketing, Neuroimmunology

Product MarketingPosted on Nov 11
Full-timeSan Francisco Bay Area, CA, USA

About the Job

Requirements

  • A bachelor's degree is required.
  • Approximately 15 or more years of progressive biopharmaceutical commercial experience, including significant marketing leadership responsibility, is required.
  • Demonstrated experience leading a successful specialty, rare disease, neurology, immunology, or hospital-based product launch is required.
  • Strong upstream and downstream marketing experience, including positioning, segmentation, targeting, market research, HCP strategy, omnichannel execution, and launch planning, is required.
  • Experience working effectively in highly cross-functional environments involving Medical Affairs, Market Access, Sales, Regulatory, Legal, Finance, Analytics, and Operations is required.
  • Strong executive communication and influencing capabilities are required.
  • A track record of building teams and developing high-performing talent is required.

Responsibilities

  • Own the integrated commercial and marketing strategy for the neuroimmunology portfolio, from pre-launch through commercialization and lifecycle management.
  • Develop differentiated positioning, value proposition, messaging, segmentation, targeting, and customer engagement strategies grounded in patient and HCP insights.
  • Translate clinical evidence, disease burden, treatment pathways, and competitive dynamics into a clear and compelling commercial narrative.
  • Identify critical adoption drivers and barriers and develop strategies to accelerate appropriate utilization.
  • Serve as a senior leader for launch strategy and operational readiness, establishing clear milestones, KPIs, decision points, and organizational priorities.
  • Build and execute the launch plan across HCP marketing, field execution, digital and omnichannel engagement, congresses, peer-to-peer education, advocacy, and market development.
  • Ensure tight integration across Marketing, Sales, Market Access, Medical Affairs, Patient Services, Supply/Trade, and Analytics.
  • Develop launch scenarios and adapt strategy based on market insights, customer feedback, competitive developments, and early performance.
  • Develop a deep understanding of the neuroimmunology treatment ecosystem, including specialists, hospitals and health systems, pharmacists, multidisciplinary care teams, patients, and advocacy organizations.
  • Build customer journeys and engagement strategies for priority HCP and institutional segments.
  • Lead advisory boards, market research, message testing, and other insight-generation activities.
  • Partner with field leadership to translate strategy into actionable execution at the account and territory level.
  • Lead disease education and market development strategies to improve recognition of disease burden, unmet need, appropriate diagnosis and treatment, and urgency of intervention.
  • Identify opportunities to reshape treatment paradigms and establish a new standard of care.
  • Partner with Medical Affairs and advocacy stakeholders while maintaining appropriate functional independence and compliance.
  • Establish commercial KPIs and leading indicators to assess launch readiness and post-launch performance.
  • Use quantitative and qualitative insights to optimize targeting, messaging, channel mix, and resource allocation.
  • Partner with forecasting and analytics teams to inform patient-based forecasts, scenario planning, market assumptions, and investment decisions.
  • Build and develop a high-performing marketing organization as the portfolio progresses toward commercialization.
  • Lead agencies and external partners with strategic and financial discipline.
  • Establish a culture of ownership, urgency, accountability, collaboration, and high-quality execution.
  • Communicate commercial strategy and performance effectively to executive leadership and other senior stakeholders.

Desired Qualifications

  • An MBA or other advanced degree is preferred.
  • Direct experience in neurology, neuroimmunology, immunology, rare disease, or acute hospital-based therapeutics is preferred.
  • Experience commercializing products where site-of-care economics, formulary access, coding and reimbursement, and institutional adoption materially influence uptake is preferred.
  • Experience establishing or disrupting a treatment paradigm rather than competing within a mature category is preferred.
  • Experience working in a pre-commercial or rapidly scaling biotechnology organization is preferred.

About the Company

Annexon Biosciences

Develops C1q inhibitor therapies

Annexon Biosciences develops therapies that target the classical complement pathway to treat autoimmune and neurodegenerative diseases, including eye conditions. Its main strategy is to inhibit C1q, the molecule that starts the complement cascade, with the aim of stopping disease progression at its source. The company advances therapies through clinical trials and may either commercialize them or partner with larger pharma firms to bring them to market. Revenue potential comes from product sales, licensing, and milestone payments from collaborations. Annexon’s goal is to deliver first-in-class C1q inhibitors that prevent tissue damage across diseases such as Alzheimer's, Huntington's, glaucoma, and related disorders, supported by substantial financing to push its pipeline forward.

Company size
51-200
Company stage
IPO
Headquarters
San Francisco, CA
Founded
2011

Recently Posted Jobs

Explore more opportunities at Annexon Biosciences

See more jobs